In February 2025, the FDA announced that the semaglutide shortage had been resolved
Its safety, efficacy, and appropriate handling in humans or animals have not been established
Injectable timelines are not trial-validated
In patients with DM2 the incretin response is diminished, but the insulinotropic effect of GLP-1 is conserved.28 Under normal conditions GLP-1 has a short half-life (approximately 2 min), as it is rapidly degraded by dipeptidylpeptidase 4, so GLP-1 analogues resistant to this enzyme have been developed for the treatment of DM2.29 arGLP-1: glucagon-like peptide 1 receptor agonist
Do not exceed recommended doses
GLP-1 Support Patch FAQS A GLP-1 Support Patch is a non-pharmaceutical transdermal wellness patch designed to deliver vitamins, minerals, and botanical ingredients through the skin to support metabolic and nutritional wellness routines